Concepedia

Kirsten Leu

KL

Statistics

Publications

10

Citations

884

H-Index

10

Active since

2001

Affiliations

University of Michigan(Current)

Nebraska Methodist College

Fox Chase Cancer Center

Northwestern University

University of Rochester

Kirsten Leu is an author at University of Michigan specializing in oncology, medicine, and chemotherapy.

Publications per year

2001–2021

10

Publications

10

Laboratory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treament With Gemcitabine Followed by Docetaxel in the Treatment of Sarcoma

Kirsten Leu, Leo J. Ostruszka, Donna S. Shewach et al. · Journal of Clinical Oncology · 2004 · 245 citations · Full text

, , +16

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Megan Othus, Sandip Pravin Patel, Chris Ryan et al. · Journal for ImmunoTherapy of Cancer · 2021 · 159 citations · Full text

, , +17

Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor

Scott M. Schuetze, Vanessa Bolejack, Edwin Choy et al. · Cancer · 2016 · 132 citations · Full text

, , +16

Cytochrome P450 CYP3A4/5 Expression as a Biomarker of Outcome in Osteosarcoma

Hassan R. Dhaini, Dafydd G. Thomas, Thomas J. Giordano et al. · Journal of Clinical Oncology · 2003 · 105 citations

, , +17

Phase II Study of 9-Nitro-Camptothecin in Patients With Advanced Chordoma or Soft Tissue Sarcoma

Rashmi Chugh, Rodney L. Dunn, Mark M. Zalupski et al. · Journal of Clinical Oncology · 2005 · 94 citations · Full text

, , +15

1–5 of 10